Hong Zhu

17PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nutritional epidemiologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 29, 2026
Extended-field intensity-modulated radiation therapy and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic or common iliac lymph nodes: a multicenter prospective cohort study.

|Apr 29, 2026
Association Between Maternal Diabetes and the Risk of Cancers in Mother-Offspring: A Meta-Analysis of 44.9 Million Pregnancies.

|Mar 14, 2026
Comprehensive Comparison of Surgery Followed by Radiotherapy and Radical Radiotherapy for Cervical Cancer: A Multicenter Retrospective Propensity-Score-Matched Analysis.

Junyi Liu, Youwen Zhu, Kun Liu

|Jan 01, 2026
International Cost-Effectiveness Analysis of Nivolumab Versus Brentuximab Vedotin for Patients With Advanced-Stage Classic Hodgkin's Lymphoma.

Youwen Zhu, Kun Liu, Steven T Rosen

|Jul 07, 2025
International cost-effectiveness analysis of chemoradiotherapy plus pembrolizumab for locally advanced cervical cancer.

Kun Liu, Youwen Zhu, Hong Zhu

|Jun 25, 2025
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study.

Lingfang Xia, Keqiang Zhang, Ying Tang

Pageof 3

Frequent Collaborators

6 joint publications

Youwen Zhu

5 joint publications

Kun Liu

1 joint publications

Qiuping Yang

1 joint publications

Hui Cao